Literature DB >> 32203383

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies.

Rafael Pinilla-Redondo1,2,3, Bálint Csörgő1,4, Nicole D Marino1, Joseph Bondy-Denomy5,6,7.   

Abstract

Clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes, a diverse family of prokaryotic adaptive immune systems, have emerged as a biotechnological tool and therapeutic. The discovery of protein inhibitors of CRISPR-Cas systems, called anti-CRISPR (Acr) proteins, enables the development of more controllable and precise CRISPR-Cas tools. Here we discuss applications of Acr proteins for post-translational control of CRISPR-Cas systems in prokaryotic and mammalian cells, organisms and ecosystems.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32203383      PMCID: PMC8510557          DOI: 10.1038/s41592-020-0771-6

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  88 in total

1.  Unexpected CRISPR on-target effects.

Authors:  Hyunji Lee; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2018-07-30       Impact factor: 54.908

Review 2.  Phage-Encoded Anti-CRISPR Defenses.

Authors:  Sabrina Y Stanley; Karen L Maxwell
Journal:  Annu Rev Genet       Date:  2018-09-12       Impact factor: 16.830

Review 3.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

4.  A multifunctional AAV-CRISPR-Cas9 and its host response.

Authors:  Wei Leong Chew; Mohammadsharif Tabebordbar; Jason K W Cheng; Prashant Mali; Elizabeth Y Wu; Alex H M Ng; Kexian Zhu; Amy J Wagers; George M Church
Journal:  Nat Methods       Date:  2016-09-05       Impact factor: 28.547

Review 5.  The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.

Authors:  Adair L Borges; Alan R Davidson; Joseph Bondy-Denomy
Journal:  Annu Rev Virol       Date:  2017-07-27       Impact factor: 10.431

6.  Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.

Authors:  Dan Wang; Haiwei Mou; Shaoyong Li; Yingxiang Li; Soren Hough; Karen Tran; Jia Li; Hao Yin; Daniel G Anderson; Erik J Sontheimer; Zhiping Weng; Guangping Gao; Wen Xue
Journal:  Hum Gene Ther       Date:  2015-07       Impact factor: 5.695

7.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

8.  p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.

Authors:  Robert J Ihry; Kathleen A Worringer; Max R Salick; Elizabeth Frias; Daniel Ho; Kraig Theriault; Sravya Kommineni; Julie Chen; Marie Sondey; Chaoyang Ye; Ranjit Randhawa; Tripti Kulkarni; Zinger Yang; Gregory McAllister; Carsten Russ; John Reece-Hoyes; William Forrester; Gregory R Hoffman; Ricardo Dolmetsch; Ajamete Kaykas
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

Review 9.  The CRISPR tool kit for genome editing and beyond.

Authors:  Mazhar Adli
Journal:  Nat Commun       Date:  2018-05-15       Impact factor: 14.919

10.  HDAd5/35++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells.

Authors:  Chang Li; Nikoletta Psatha; Sucheol Gil; Hongjie Wang; Thalia Papayannopoulou; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2018-05-01       Impact factor: 6.698

View more
  45 in total

1.  Immunotherapy perspectives in the new era of B-cell editing.

Authors:  Natsuko Ueda; Marine Cahen; Yannic Danger; Jérôme Moreaux; Christophe Sirac; Michel Cogné
Journal:  Blood Adv       Date:  2021-03-23

Review 2.  Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.

Authors:  Ning Jia; Dinshaw J Patel
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-04       Impact factor: 94.444

Review 3.  In vivo locus-specific editing of the neuroepigenome.

Authors:  Yun Young Yim; Collin D Teague; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2020-07-23       Impact factor: 34.870

4.  A CRISPR/Anti-CRISPR Genome Editing Approach Underlines the Synergy of Butanol Dehydrogenases in Clostridium acetobutylicum DSM 792.

Authors:  François Wasels; Gwladys Chartier; Rémi Hocq; Nicolas Lopes Ferreira
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

5.  PaCRISPR: a server for predicting and visualizing anti-CRISPR proteins.

Authors:  Jiawei Wang; Wei Dai; Jiahui Li; Ruopeng Xie; Rhys A Dunstan; Christopher Stubenrauch; Yanju Zhang; Trevor Lithgow
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

6.  Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.

Authors:  Guoxu Song; Fei Zhang; Chunhong Tian; Xing Gao; Xiaoxiao Zhu; Dongdong Fan; Yong Tian
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

Review 7.  Anti-CRISPRs go viral: The infection biology of CRISPR-Cas inhibitors.

Authors:  Yuping Li; Joseph Bondy-Denomy
Journal:  Cell Host Microbe       Date:  2021-01-13       Impact factor: 21.023

Review 8.  Controlling and enhancing CRISPR systems.

Authors:  Haridha Shivram; Brady F Cress; Gavin J Knott; Jennifer A Doudna
Journal:  Nat Chem Biol       Date:  2020-12-16       Impact factor: 15.040

9.  Crystal structure of the anti-CRISPR repressor Aca2.

Authors:  Ben Usher; Nils Birkholz; Izaak N Beck; Robert D Fagerlund; Simon A Jackson; Peter C Fineran; Tim R Blower
Journal:  J Struct Biol       Date:  2021-06-08       Impact factor: 2.867

10.  Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9.

Authors:  Zhiquan Liu; Siyu Chen; Wanhua Xie; Yuning Song; Jinze Li; Liangxue Lai; Zhanjun Li
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.